Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute on Drug Abuse (NIDA)
With
New York MDRU
The objective of this study is to provide follow-up compassionate use treatment and evaluate long term safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment for subjects who have completed Cooperative Study 1008 A and B.
Age
18–59
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
\- Completion of Cooperative Study 1008 A/B
You may not be if
\- Significant medical or psychiatric illness. Non-compliance with study procedures in the Cooperative Study 1008 A/B
